Latest Breaking News On - Todd girolamo - Page 1 : vimarsana.com

Stock awards continue as bulk of ProKidney exec compensation

Stock awards continue as bulk of ProKidney exec compensation
journalnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalnow.com Daily Mail and Mail on Sunday newspapers.

James coulstonTim bertramTodd girolamoDeepak jainBruce culletonBusiness centerProkidney corpGreenbourne drive

ProKidney Corp Reports Second Quarter 2022 Financial

Completed business combination with Social Capital Suvretta Holdings, III.

United statesKerry cooperNuvation bioLibbie mckenzieDburns mcclellanJennifer foxTim bertramTodd girolamoLee rothJohnm maraganoreProkidney corpUs healthAlnylam pharmaceuticals incExchange commissionCompany classCapital suvretta holdings corp

ProKidney Corp Reports Second Quarter 2022 Financial Results and Provides Business Update

ProKidney Corp Reports Second Quarter 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKerry cooperLee rothburns mcclellanNuvation bioLibbie mckenzieJennifer foxTim bertramTodd girolamoJohnm maraganoreProkidney corpUs healthAlnylam pharmaceuticals incExchange commissionCompany classCapital suvretta holdings corpSocial capital suvretta holdings

Longeveron Inc Provides Corporate Update and Reports First

Conference call scheduled for 8:30 a.m. ET today.

United statesNova scotiaTodd girolamoElsie yauVagelos college of physiciansCaladrius biosciences incJournal of the alzheimer associationJuntendo university hospital tokyoRockefeller universityBlood instituteNational centerMerck research laboratoriesDrug administrationLongeveron incColumbia universityExchange commission

Longeveron Inc Provides Corporate Update and Reports First Quarter 2022 Financial Results

13.05.2022 - Conference call scheduled for 8:30 a.m. ET todayMIAMI, May 13, 2022 (GLOBE NEWSWIRE) - Longeveron Inc. (NASDAQ: LGVN) ( Longeveron or Company ), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and .

United statesNova scotiaTodd girolamoElsie yauVagelos college of physiciansCaladrius biosciences incJournal of the alzheimer associationJuntendo university hospital tokyoRockefeller universityBlood instituteNational centerMerck research laboratoriesForgiveness of paycheck protection programDrug administrationLongeveron incColumbia university